Title: How Molecule Mob in a Lobby Influences Gene Behavior: Insights from Quanta Magazine Introduction: The intricate workings of our...
Phase IIb trial results have recently revealed that Tozorakimab, a potential treatment for diabetic kidney disease (DKD), did not meet...
Colombia’s Advancements in Cannabis Legalization: A Progressive Journey In recent years, Colombia has emerged as a global leader in cannabis...
Nature Communications: A Groundbreaking Study on the Successful Generation of Patterned Branchial Arch-like Aggregates from Human Pluripotent Stem Cells Using...
Royal Queen Seeds, a renowned cannabis seed bank, has recently been selected as the exclusive partner for the TYSON 2.0...
Potential for cancer treatment demonstrated by metal-free graphene quantum dots Graphene, a two-dimensional material made up of a single layer...
Correction by Publisher: Study reveals the role of hypoblast derived from human pluripotent stem cells in regulating epiblast development, as...
Understanding the Transcriptional Regulatory Network Controlling Human Trophoblast Stem Cells in Extravillous Trophoblast Differentiation – Insights from Nature Communications The...
Anne Ephrussi is a renowned scientist who has made significant contributions to the field of molecular biology. Her groundbreaking research...
Title: Unveiling the Intriguing Influence of LIN28A’s Non-Canonical Function on Pluripotent Stem Cell Fate Decisions: A Study in Nature Communications...
Metagenomi, a Biotech Company Specializing in Gene Editing, Successfully Completes IPO Raising Close to $94 Million Metagenomi, a leading biotech...
The Association Between Cellular Senescence and Osteonecrosis of the Femoral Head, and the Inhibitory Effects of Mesenchymal Stem Cell Conditioned...
Scientific Reports: A Study on the Creation of African Pygmy Mouse Induced Pluripotent Stem Cells through Defined Doxycycline Inducible Transcription...
Osteoporosis is a common bone disease characterized by low bone mass and deterioration of bone tissue, leading to an increased...
Phase I Thromboembolic Disorder Trial Commences Subject Dosing by Sirius Sirius Pharmaceuticals, a leading biopharmaceutical company, has announced the commencement...
